Edward W. Frykman
Direttore/Membro del Consiglio presso Unidym, Inc.
Profilo
Edward W.
Frykman currently works at Unidym, Inc., as Director, Ablaris Therapeutics, Inc., as Director, and Tego Biosciences Corp., as Director.
Mr. Frykman also formerly worked at Acacia Research Corp., as Director from 1996 to 2007, Arrowhead Pharmaceuticals, Inc., as Independent Director, Calando Pharmaceuticals, Inc., as Director, Insert Therapeutics, Inc., as Director, Acacia Research Corp., as Independent Director from 2011 to 2018, Crowell Weedon & Co., as Account Executive from 1992 to 2008, E.
F.
Hutton & Co., as Manager-Los Angeles Retail Office, Shearson Lehman Hutton, Inc., as Senior Account Executive, and LH Friend & Co., as Senior Vice President.
Mr. Frykman received his undergraduate degree from the University of Florida.
Posizioni attive di Edward W. Frykman
| Società | Posizione | Inizio |
|---|---|---|
Unidym, Inc.
 Unidym, Inc. Electronic Production EquipmentElectronic Technology Unidym, Inc. manufactures, develops, and applies carbon nanotubes. It also provides bulk materials to customers and business partners. The company was founded in 2005 and is headquartered in Sunnyvale, CA. | Direttore/Membro del Consiglio | - |
| Ablaris Therapeutics, Inc. | Direttore/Membro del Consiglio | - |
| Tego Biosciences Corp. | Direttore/Membro del Consiglio | - |
Precedenti posizioni note di Edward W. Frykman
| Società | Posizione | Fine |
|---|---|---|
| ACACIA RESEARCH CORPORATION | Direttore/Membro del Consiglio | 14/04/2018 |
Insert Therapeutics, Inc.
 Insert Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Insert Therapeutics, Inc. researches and develops therapeutic products. It is using nano-engineered, polymeric delivery system, Cyclosert(TM), to design, develop and commercialize drug-delivery-enhanced small-molecule therapeutics and nucleic acids. Cyclosert uses cyclodextrins as building blocks to create biocompatible materials - linear cyclodextrin-containing polymers that are non-toxic and non-immunogenic at therapeutic doses. The company was founded in February 2000 by Mark Davis and is located in Pasadena, CA | Direttore/Membro del Consiglio | 08/09/2008 |
Crowell Weedon & Co.
 Crowell Weedon & Co. Investment Banks/BrokersFinance Founded in 1932, Crowell Weedon & Co. is full service stock brokerage and money management firm headquartered in Los Angeles, California. The firm is a subsidiary of D. A. Davidson & Co. and their ultimate parents is the Davidson Cos. | Corporate Officer/Principal | 01/01/2008 |
| Acacia Research Corp. /Old/ | Direttore/Membro del Consiglio | 16/08/2007 |
| Shearson Lehman Hutton, Inc. | Corporate Officer/Principal | - |
Formazione di Edward W. Frykman
| University of Florida | Undergraduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 2 |
|---|---|
| ARROWHEAD PHARMACEUTICALS, INC. | Health Technology |
| ACACIA RESEARCH CORPORATION | Commercial Services |
| Aziende private | 10 |
|---|---|
| Acacia Research Corp. /Old/ | Finance |
Calando Pharmaceuticals, Inc.
 Calando Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Calando Pharmaceuticals, Inc. engages in the design and development of drug-delivery-enhanced small molecule therapeutics. The company was established in 2000 and is headquartered in Pasadena, CA. | Health Technology |
Crowell Weedon & Co.
Crowell Weedon & Co. Investment Banks/BrokersFinance Founded in 1932, Crowell Weedon & Co. is full service stock brokerage and money management firm headquartered in Los Angeles, California. The firm is a subsidiary of D. A. Davidson & Co. and their ultimate parents is the Davidson Cos. | Finance |
Insert Therapeutics, Inc.
Insert Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Insert Therapeutics, Inc. researches and develops therapeutic products. It is using nano-engineered, polymeric delivery system, Cyclosert(TM), to design, develop and commercialize drug-delivery-enhanced small-molecule therapeutics and nucleic acids. Cyclosert uses cyclodextrins as building blocks to create biocompatible materials - linear cyclodextrin-containing polymers that are non-toxic and non-immunogenic at therapeutic doses. The company was founded in February 2000 by Mark Davis and is located in Pasadena, CA | Commercial Services |
| E. F. Hutton & Co. | Finance |
Unidym, Inc.
Unidym, Inc. Electronic Production EquipmentElectronic Technology Unidym, Inc. manufactures, develops, and applies carbon nanotubes. It also provides bulk materials to customers and business partners. The company was founded in 2005 and is headquartered in Sunnyvale, CA. | Electronic Technology |
| Shearson Lehman Hutton, Inc. | Finance |
| Ablaris Therapeutics, Inc. | |
| Tego Biosciences Corp. | |
| LH Friend & Co. |
- Borsa valori
- Insiders
- Edward W. Frykman
